tradingkey.logo
tradingkey.logo
Search

Ecolab Q3 Organic Sales Rise 7% as High-Tech and Life Sciences Drive Growth

TradingKeyOct 28, 2026 9:12 AM
facebooktwitterlinkedin
View all comments(0)

Ecolab reported strong third-quarter 2026 performance, driven by accelerated organic sales growth, robust pricing, and significant expansions in High-Tech and Life Sciences segments. Net sales increased 13% to $4.69 billion, while adjusted operating income rose 14%. However, acquisition-related amortization and financing costs from CoolIT Systems created near-term headwinds, dampening adjusted EPS growth. For the full year, Ecolab projects adjusted diluted EPS of $8.10 to $8.20 and maintains long-term operating margin targets. Key risks include geopolitical volatility, rising commodity costs, and increased leverage following recent strategic acquisitions.

AI-generated summary

Ecolab Inc. (NYSE: ECL) reported faster organic sales growth and double-digit operating income gains for the third quarter of 2026, supported by strong pricing, new customer wins and rapid expansion in its High-Tech and Life Sciences businesses. Adjusted earnings growth was more modest, however, as amortization and financing costs related to the CoolIT Systems acquisition created a significant near-term headwind.

Third-quarter net sales increased 13% to $4.69 billion. Organic sales, which exclude currency effects and the initial impact of acquisitions and divestitures, rose 7%, with volume growth of 2% and pricing gains of 5%. Ecolab said stronger new business helped offset continued customer disruptions in the Middle East.

Reported operating income increased 7% to $810.5 million, while the reported operating margin declined 100 basis points to 17.3%. Adjusted operating income rose 14% to $893.4 million, with the adjusted margin edging up 10 basis points to 19.0%. Organic operating income grew 11% to $872.1 million, and the organic operating margin expanded 70 basis points to 19.6% as pricing, sales growth and productivity more than offset higher commodity costs and growth investments.

Reported diluted earnings per share were $1.95, compared with $2.05 a year earlier. Adjusted diluted EPS increased 5% to $2.18. The company said CoolIT-related amortization and financing costs reduced third-quarter adjusted EPS growth by approximately 10 percentage points.

Gross margin fell 70 basis points to 44.1%, reflecting the impact of recent acquisitions. Organic gross margin was broadly stable at 44.9% as stronger pricing offset higher commodity expenses. Selling, general and administrative costs declined as a percentage of sales to 25.1% from 25.9%, helped by productivity and the effect of acquisitions.

High-Tech and Life Sciences lead growth

Global Water organic sales rose 9%, led by a 63% increase in High-Tech. High-Tech fixed-currency sales climbed 293% after including the Ovivo Electronics and CoolIT acquisitions. Organic growth was driven by new business across data centers and microelectronics, including demand for liquid-cooling infrastructure and water-management systems used in semiconductor production.

Food & Beverage organic sales increased 8% on broad-based new business and improved pricing. Paper sales rose 6%, supported by wins in board, packaging and pulp, while Light Water advanced 5%. Heavy Water returned to 4% growth as downstream gains and stable basic-industry sales offset weaker conditions in primary metals and softer performance in the Middle East.

Global Water operating income increased 24% to $445.2 million, partly reflecting acquired operations. On an organic basis, operating income rose 9%, and the organic margin increased 10 basis points to 17.5%.

Global Life Sciences delivered 17% organic sales growth, reflecting strong new business and share gains in bioprocessing, personal care and purification, as well as a favorable comparison with prior-year plant maintenance. Organic operating income jumped 49% to $50.2 million, lifting the segment’s margin by 500 basis points to 23.3%. Supply-chain efficiencies and higher sales more than offset commodity inflation and continued investment in innovation, capacity and global capabilities.

Pest Elimination organic sales increased 8%, led by customer wins in food and beverage, food retail and restaurants. Organic operating income rose 7%, though its margin slipped 10 basis points to 20.8% as Ecolab invested in deploying its Pest Intelligence platform. Management expects the segment’s margin to remain in the high-teens to 20% range over the next few quarters while those investments continue.

Global Institutional & Specialty posted 3% organic sales growth. Institutional sales rose 2% as pricing and new business offset softer industry conditions, including a mid-single-digit decline in North American restaurant traffic. Specialty sales increased 5%, driven by new business and pricing in quick-service restaurants and food retail. Segment operating income rose 8% to $404.9 million, while its margin expanded 110 basis points to 24.7%.

Fourth-quarter and full-year outlook

For the fourth quarter, Ecolab expects reported sales growth of 12% to 14%, including contributions from Ovivo Electronics and CoolIT, and organic sales growth of 6% to 7%. The company anticipates an adjusted operating income margin of approximately 19% and an organic operating income margin of about 20%.

Fourth-quarter adjusted diluted EPS is expected to range from $2.13 to $2.23, representing growth of 2% to 7%. That forecast includes an estimated 12-percentage-point headwind from CoolIT-related amortization and financing costs.

Ecolab expects full-year 2026 adjusted diluted EPS of $8.10 to $8.20, up 8% to 9%. The range incorporates an approximately six-percentage-point CoolIT-related headwind. Management also maintained its expectation that the adjusted operating income margin will reach 20% in 2027. Its longer-term targets call for organic sales growth of 5% to 7%, annual operating-margin expansion of 100 to 150 basis points and adjusted EPS growth of 12% to 15%.

The company identified geopolitical volatility, changing international trade policies, rising commodity costs and Middle East customer disruptions as near-term operating challenges. Its balance sheet also reflects increased acquisition-related leverage: net debt to adjusted EBITDA was 2.9 times at Sept. 30, 2026, compared with 1.6 times a year earlier. Long-term debt rose to $11.92 billion from $8.05 billion, while cash declined to $722.3 million from $1.96 billion.

Cash from operating activities totaled $1.94 billion for the first nine months of 2026, compared with $1.86 billion a year earlier, while capital expenditures increased to $902 million from $716.2 million.

This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.